U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 1025

Variation
Gene
(Protein Change)
Type
(Consequence)
ConditionClassification, Review status
ABR, ABR-AS1
+962 more
Copy number gain
See cases
GPathogenic
LOC130060335, LOC130060336
+242 more
Copy number gain
See cases
GPathogenic
ADORA2B, ARHGAP44
+228 more
Duplication
not specified
GPathogenic
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(3 prime UTR variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(R823fs +2 more)
Microsatellite
(frameshift variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(V783I +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(V823F +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(K782T +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(A780G +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(A780T +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(Q779H +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Prostate cancer, hereditary, 2
+1 more
GLikely benign
ELAC2
(Q818* +2 more)
Single nucleotide variant
(nonsense)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(E777K +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(E777del +2 more)
Deletion
(inframe_deletion)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(R811Q +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(R811W +2 more)
Single nucleotide variant
(missense variant)
not provided
+2 more
GUncertain significance
ELAC2
(Q769L +2 more)
Single nucleotide variant
(missense variant)
Inborn genetic diseases
+1 more
GUncertain significance
ELAC2
(P807L +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(P807S +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(E767K +2 more)
Single nucleotide variant
(missense variant)
Inborn genetic diseases
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Duplication
(inframe_insertion)
Combined oxidative phosphorylation defect type 17
+2 more
GConflicting classifications of pathogenicity
ELAC2
Insertion
(inframe_insertion)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(E764D +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(E804fs +2 more)
Deletion
(frameshift variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
not specified
+2 more
GLikely benign
ELAC2
(G802S +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
not provided
+1 more
GLikely benign
ELAC2
(G800D +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(E758S +2 more)
Inversion
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(E758L +2 more)
Indel
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(R757K +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(L755P +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(L754F +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Deletion
(inframe_indel)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(synonymous variant)
Prostate cancer, hereditary, 2
+2 more
GLikely benign
ELAC2
(A792V +2 more)
Single nucleotide variant
(missense variant)
not provided
+3 more
GUncertain significance
ELAC2
Duplication
(inframe_insertion)
Inborn genetic diseases
+1 more
GUncertain significance
ELAC2
(A791T +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(R791Q +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
+1 more
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(V790M +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(Q789H +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(R788Q +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(R785W +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(K783R +2 more)
Single nucleotide variant
(missense variant)
not provided
+1 more
GConflicting classifications of pathogenicity
ELAC2
Deletion
(inframe_deletion)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(R780L +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(R781H +2 more)
Single nucleotide variant
(missense variant)
Inborn genetic diseases
+2 more
GConflicting classifications of pathogenicity
ELAC2
(R780C +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(M777T +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(M738L +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(E775K +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
+1 more
GLikely benign
ELAC2
(I735N +2 more)
Single nucleotide variant
(missense variant)
not provided
+1 more
GUncertain significance
ELAC2
(I774V +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(D734N +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(F731fs +2 more)
Deletion
(frameshift variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(L769fs +2 more)
Deletion
(frameshift variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Duplication
(inframe_insertion)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(P726Q +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(I724S +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(synonymous variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
(T759A +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(D755fs +2 more)
Microsatellite
(frameshift variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
(V712A +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(splice acceptor variant)
ELAC2-related disorder
GLikely pathogenic
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
+1 more
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Deletion
(intron variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GBenign
ELAC2
Single nucleotide variant
(intron variant)
not provided
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Microsatellite
(intron variant)
Combined oxidative phosphorylation defect type 17
GLikely benign
ELAC2
Single nucleotide variant
(splice donor variant)
Inborn genetic diseases
GUncertain significance
ELAC2
(M750T +2 more)
Single nucleotide variant
(missense variant)
Combined oxidative phosphorylation defect type 17
GUncertain significance
Format
Items per page
Sort by
Choose Destination